Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cisplatin neuropathy with Lhermitte's sign.

Literature DB >> 3007675

Cisplatin neuropathy with Lhermitte's sign.

J Dewar, H Lunt, D A Abernethy, P Dady, L F Haas.

Abstract

Following chemotherapy with cis-diamminedichloroplatinum II (cisplatin) three patients developed Lhermitte's sign and peripheral neuropathy. The toxic side effects did not become apparent until after treatment had ceased. Because of increasing use of cisplatin to achieve lasting remission in patients with malignant disease proprioceptive and myelopathic side effects may become increasingly common.

Entities: Chemical Disease Species

Mesh：

Substances：
Cisplatin

Year: 1986 PMID： 3007675 PMCID： PMC1028656 DOI： 10.1136/jnnp.49.1.96

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

15 in total

1. TRANSIENT RADIATION MYELOPATHY (WITH REFERENCE TO LHERMITTE'S SIGN OF ELECTRICAL PARAESTHESIA).

Authors: A JONES
Journal: Br J Radiol Date: 1964-10 Impact factor: 3.039

2. Sensory conduction in medial plantar nerve: normal values, clinical applications, and a comparison with the sural and upper limb sensory nerve action potentials in peripheral neuropathy.

Authors: R J Guiloff; R M Sherratt
Journal: J Neurol Neurosurg Psychiatry Date: 1977-12 Impact factor: 10.154

3. Automatic analysis of the EMG interference pattern.

Authors: E Stålberg; J Chu; V Bril; S Nandedkar; S Stålberg; M Ericsson
Journal: Electroencephalogr Clin Neurophysiol Date: 1983-12

4. Neurotoxicity of antineoplastic drugs.

Authors: R S Kaplan; P H Wiernik
Journal: Semin Oncol Date: 1982-03 Impact factor: 4.929

5. The superficial radial nerve: techniques for evaluation.

Authors: J F Critchlow; M E Seybold; C J Jablecki
Journal: J Neurol Neurosurg Psychiatry Date: 1980-10 Impact factor: 10.154

6. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors: S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal: Cancer Date: 1984-10-01 Impact factor: 6.860

7. Subacute sensory neuropathy: a remote effect of carcinoma.

Authors: M S Horwich; L Cho; R S Porro; J B Posner
Journal: Ann Neurol Date: 1977-07 Impact factor: 10.422

8. Cisplatin-induced autonomic neuropathy.

Authors: C S Rosenfeld; L E Broder
Journal: Cancer Treat Rep Date: 1984-04

9. Neurotoxic effects of cisplatin therapy.

Authors: T J Walsh; A W Clark; I M Parhad; W R Green
Journal: Arch Neurol Date: 1982-11

10. Peripheral sensory neuropathy and cisplatin chemotherapy.

Authors: R I Roelofs; W Hrushesky; J Rogin; L Rosenberg
Journal: Neurology Date: 1984-07 Impact factor: 9.910

11 in total

Review 1. On the significance of Lhermitte's sign in oncology.

Authors: V Ventafridda; A Caraceni; C Martini; A Sbanotto; F De Conno
Journal: J Neurooncol Date: 1991-04 Impact factor: 4.130

2. 'Out of blue' Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin.

Authors: J M Jurado; B Pajares; D Olmos; I Sevilla; E Alba
Journal: Ann Oncol Date: 2008-10-31 Impact factor: 32.976

3. Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement.

Authors: W Boogerd; W W ten Bokkel Huinink; O Dalesio; W J Hoppenbrouwers; J J van der Sande
Journal: J Neurooncol Date: 1990-12 Impact factor: 4.130

4. Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.

Authors: G Bogliun; L Marzorati; G Cavaletti; L Frattola
Journal: Ital J Neurol Sci Date: 1992-11